Novo Nordisk
NVO
#19
Rank
C$671.38 B
Marketcap
$147.90
Share price
-1.49%
Change (1 day)
8.83%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$58.25 Billion

According to Novo Nordisk's latest financial reports the company's total liabilities are C$58.25 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novo Nordisk - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$40.84 B32.48%
2022-12-31C$30.83 B28.39%
2021-12-31C$24.01 B39.63%
2020-12-31C$17.19 B29.12%
2019-12-31C$13.31 B8.3%
2018-12-31C$12.29 B15.49%
2017-12-31C$10.64 B7.07%
2016-12-31C$9.94 B9.13%
2015-12-31C$9.11 B30.77%
2014-12-31C$6.96 B27.34%
2013-12-31C$5.47 B23.97%
2012-12-31C$4.41 B-8.58%
2011-12-31C$4.82 B10.77%
2010-12-31C$4.35 B13.15%
2009-12-31C$3.85 B-4.5%
2008-12-31C$4.03 B32.69%
2007-12-31C$3.04 B1.09%
2006-12-31C$3.00 B14.05%
2005-12-31C$2.63 B9.54%
2004-12-31C$2.40 B19.33%
2003-12-31C$2.01 B3.81%
2002-12-31C$1.94 B-3.01%
2001-12-31C$2.00 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$178.23 B 205.95%๐Ÿ‡บ๐Ÿ‡ธ USA
C$86.06 B 47.74%๐Ÿ‡บ๐Ÿ‡ธ USA
C$107.38 B 84.34%๐Ÿ‡บ๐Ÿ‡ธ USA
C$85.44 B 46.67%๐Ÿ‡ซ๐Ÿ‡ท France